Related Experiment Video
Updated: May 30, 2025

A Precision Medicine Tool for Measurement and Monitoring of Hemoglobin S in Sickle Cell Disease Patients Receiving Transfusion Therapy
Sickle Cell Disease: A Potential Cause of Immune Thrombocytopenia
Abdulwahab Ahmed A Alkhars1, Mohammed A Alkadi1, Hussain M Alwabari1
1Internal Medicine, King Fahad Hospital Hofuf, Hofuf, SAU.
Abstract:
Sickle cell anemia (SCA) is one of the known hemoglobinopathies that result in red blood cell (RBC) destruction, among other complications. There are factors that make SCA an environment for autoimmune disease (AID). They include chronic inflammation, immune-mediated processes involved in SCA complications, and susceptibility to infections. Furthermore, immune thrombocytopenia (ITP) is a complex disorder characterized by immune imbalance that results in platelet destruction. We report a case of a 20-year-old patient with SCA presenting with a vaso-occlusive crisis (VOC) and unexplained thrombocytopenia. After ruling out secondary causes of the latter condition, the patient was challenged with steroid therapy. Interestingly, he showed a dramatic response in platelet count. This report emphasizes the potential role of SCA in the development of ITP and encourages further studies to explore the underlying immunological mechanisms.
More Related Videos
08:23Characterization of Sickling During Controlled Automated Deoxygenation with Oxygen Gradient Ektacytometry
Published on: November 5, 2019
05:23Continuous Manual Exchange Transfusion for Patients with Sickle Cell Disease: An Efficient Method to Avoid Iron Overload
Published on: March 14, 2017
Related Concept Videos
Immunodeficiency Diseases
There are three main causes of immunodeficiency...
Bone Marrow Sampling and Transplants
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
Regulation of Hematopoietic Stem Cells
Multiple Allele Traits
Disorders of Hemostasis
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Cell-mediated Immune Responses